30.09.2013 • News

Clariant Acquires Organic Pigment Business of Jiangsu Multicolor and Invests in New Plant in China

Clariant announced it has acquired the Organic Pigment business of Jiangsu Multicolor Fine Chemical (JMC) based in Jiangsu Province, PRC. JMC is a leading supplier of several types of high performance pigments and pigment preparations in China. The business recorded sales of RMB 210 million (approximately CHF 30 million). It manufactures and markets pigments and pigment preparations mainly for customers in coatings, plastics and printing inks in the domestic and export markets. 

Additionally, as part of this project, Clariant will build a world scale Pigment PV23 plant in Zhenjiang, Jiangsu Province, PRC. The plant will be designed to ensure highest yields, lowest cost and the highest efficiency in terms of sustainable operations and full compliance with local and international regulatory standards.

The bolt-on acquisition and the subsequent investment in a new plant allows Clariant to expand its pigments and pigment preparation activities in China in order to have better access to customers in the region and especially in China. The new plant, together with the other facilities in its manufacturing network, reinforces Clariant's ongoing commitment to fulfill the growing demand of customers in coatings, plastics, printing inks and other applications for high-quality products and solutions.

"The acquistion of the Jiangsu Multicolor Business and the investment in a world scale pigment plant in Zhenjiang will consolidate our position as a leader in the pigments industry and it is in line with Clariant's strategy of taking advantage of growth opportunities in Asia", says Hariolf Kottmann, CEO of Clariant.

"In line with our business strategy, this acquisition and investment enables us to further expand our manufacturing footprint in Asia and to grow in attractive segments of the pigment markets. It will strengthen our ability to capture the growing demand for high performance pigments and pigment preparations in China and in other key markets in Asia", says Marco Cenisio, Head of Clariant's Business Unit Pigments.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read